CSL Research Acceleration Initiative

CSL is a leading global biotech company that develops and delivers innovative biotherapies to help people living with life-threatening medical conditions live full lives.

CSL’s Research Acceleration Initiative aims to fast-track discovery of innovative biotherapies through partnerships between CSL and global research organizations.

Successful applicants will receive funding of up to $400,000 USD over 2 years.

Interested researchers are invited to:

  • Attend information webinars to learn more about the initiative: Webinars will be held on:
    • Weds 17th January 4pm ET/ 3pm CT / 2pm MT / 1pm PT or
    • Mon 5th February 12pm ET/ 11am CT / 10am MT / 9am PT
  • Contact Janet Prince (janet.prince@mcgill.ca) to obtain webinar links and online application submission instructions
  • Submit a non-confidential, 300-word abstract via the CSL online application portal by 27th February 2024.

The 2024 Research Acceleration Initiative will focus on research proposals that align with a CSL Therapeutic Area and are amenable to or include a Platform as illustrated below. Please see here for specific Focus Areas.

For webinar invitations and online application instructions please email Janet Prince (janet.prince@mcgill.ca)

Copyright © 2019 McGill Regenerative Medicine Network. All rights reserved. Website by KORSR Studio, Valérie Provost & ER5.